Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body Weight
- 1 May 2000
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 271 (2), 445-450
- https://doi.org/10.1006/bbrc.2000.2647
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular diseaseThe American Journal of Cardiology, 1999
- PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle CellsCirculation Research, 1998
- Triglyceride as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 1998
- Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived MacrophagesJournal of Biological Chemistry, 1998
- Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activatorsNature, 1998
- Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γCurrent Opinion in Genetics & Development, 1995
- FenofibrateDrugs, 1990